Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-institutional Phase 2/3 Trial of Fresh Frozen Plasma (FFP) in Patients With Moderate to Severe Traumatic Brain Injury (TBI)

NCT06062888 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT06062888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06062888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-institutional Phase 2/3 Trial of Fresh Frozen Plasma (FFP) in Patients With Moderate to Severe Traumatic Brain Injury (TBI)
Lead sponsor
Northwestern University
Phase
Phase 2/3
Overall status
Recruiting
Start date
February 1, 2026
Completion date
June 30, 2029
Enrollment
357 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe traumatic brain injury